6772-63-0

Usage

Uses

Used in Pharmaceutical Industry:
2-Cyclohexyl-3,4-dihydroisoquinolin-1(2H)-one is used as a key intermediate for the synthesis of various pharmaceuticals. Its unique structure and reactivity allow for the development of new drugs with potential therapeutic applications.
Used in Organic Chemistry:
2-Cyclohexyl-3,4-dihydroisoquinolin-1(2H)-one is used as a reagent in organic chemistry for the preparation of various organic compounds. Its versatility as an intermediate enables the synthesis of a wide range of bioactive molecules.
Used in Chemical Process Development:
2-Cyclohexyl-3,4-dihydroisoquinolin-1(2H)-one has potential applications in the development of new chemical processes due to its unique structure and reactivity. It can be utilized to create innovative synthetic routes and improve existing ones, leading to more efficient and sustainable chemical production methods.

Upstream product

• 28269-50-3 2-vinylbenzoic acid chloride 
• 108-91-8 cyclohexylamine 
• 27326-43-8 2-vinylbenzoic acid 
• 119-67-5 o-carboxybenzaldehyde 

Relevant academic research and scientific papers

Intramolecular Hydroamidation of ortho-Vinyl Benzamides Promoted by Potassium tert-Butoxide/N,N-Dimethylformamide

An intramolecular hydroamidation of ortho-vinyl benzamides had been developed. The reaction was promoted efficiently by potassium tert-butoxide and N,N-dimethylformamide without the need for strong oxidants or transition-metal catalysts. A series of dihyd

Nitrogenous heterocyclic compounds and hyperlipemia remedy containing the same

Disclosed are compounds represented by formula (I) and pharmaceutically acceptable salts and solvates thereof. The compounds can inhibit the biosynthesis of triglycerides in the liver and can inhibit the secretion of lipoprotein containing apolipoprotein B from the liver. Therefore, they are useful for the prevention or treatment of hyperlipidemia (particularly hyper-very-low-density-lipoproteinemia) and arteriosclerotic diseases, such as cardiac infarction, or pancreatitis induced by hyperlipidemia. wherein A represents group —CR1R2—(CH2)i— where R1and R2each represent a hydrogen atom or alkyl, —CH═CH—, —O—CH2—, or —S(O)j—CH2—; B represents a hydrogen or halogen atom; X represents —CR3R4R5, —NR6R7, —(CH2—CH═C(CH3)—CH2)p—CH2CH═C(CH3)2, alkyl, cycloalkyl, phenyl, cinnamyl, or heteroaromatic ring; Y represents —(CH2)q—, —CH═CH—, —NR8—, an oxygen atom, or a bond; Z represents carbonyl or a bond; K represents alkylene or a bond; L represents —CH═CH— or a bond; and M represents a hydrogen atom, alkyl, cycloalkyl, phenyl, heterocyclic ring, biphenyl, or diphenylmethyl.